Pines Wealth Management’s AbbVie ABBV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.96M Buy
7,808
+201
+3% +$43.2K 0.57% 38
2026
Q1
$1.65M Buy
7,607
+594
+8% +$132K 0.54% 44
2025
Q4
$1.6M Buy
7,013
+445
+7% +$101K 0.52% 47
2025
Q3
$1.52M Sell
6,568
-65
-1% -$13.2K 0.51% 43
2025
Q2
$1.26M Buy
6,633
+853
+15% +$159K 0.44% 54
2025
Q1
$1.02M Buy
5,780
+117
+2% +$22.7K 0.47% 58
2024
Q4
$992K Buy
+5,663
New +$1.04M 0.43% 58

Other funds holding ABBV

Pines Wealth Management's ABBV Position: Q2 2026 in Review

Pines Wealth Management increased its AbbVie (ABBV) stake by 2.6% in Q2 2026, buying an estimated $43.2K and bringing the position to 7,808 shares worth $1.96M. The position accounts for 0.57% of the portfolio, ranked #38.

Pines Wealth Management first reported a position in ABBV in Q4 2024 and has held it in 7 quarters since. 1,885 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

  • Pines Wealth Management held 7,808 shares of AbbVie worth $1.96M as of Q2 2026.
  • Pines Wealth Management bought 201 AbbVie shares in Q2 2026, an estimated $43.2K.
  • AbbVie made up 0.57% of Pines Wealth Management's portfolio in Q2 2026, its #38 holding.
  • Pines Wealth Management first reported a position in AbbVie in Q4 2024 and has held it in 7 quarters since.
  • 1,885 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Pines Wealth Management's 13F filing for Q2 2026, filed 22 Jul 2026.